Plant Comparison

Licorice root vs Chaga

A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.

First plant
Second plant
Show:
Plant ALicorice rootGlycyrrhiza glabraFabaceaeFull monograph →
Plant BChagaInonotus obliquusHymenochaetaceaeFull monograph →

At a glance

Licorice root and Chaga: they share 7 indicated uses (arthritis / joint pain, cold & flu, immune support, …); 3 pharmacological actions in common.

Licorice rootChaga
Constituents33
Pharmacological actions710
Indicated uses1411
Safety notes22
Cited sources2041
Indicated uses
Only Licorice root
Acid refluxBronchitisCoughIndigestionMenstrual crampsMuscle spasmRespiratory support
Shared (7)
Arthritis / joint painCold & fluImmune supportInfection (general)Inflammation (general)Skin irritationWounds
Only Chaga
Cancer (anticancer research)Metabolic supportCognitive functionCardiovascular / heart health
Pharmacological actions
Only Licorice root
AntispasmodicAntiviralExpectorantGastroprotective
Shared (3)
Anti-inflammatoryAntimicrobialImmunomodulator / immune support
Only Chaga
Anticancer (preclinical)AntioxidantNephroprotective (kidney support)Neuroprotective / cognition supportAntidiabetic (blood-sugar lowering)Hepatoprotective (liver support)Lipid-lowering

Evidence face-off — shared uses

ConditionLicorice rootChagaVerdict
Arthritis / joint pain1/101/10Comparable evidence
Cold & flu1/101/10Comparable evidence
Immune support1/102/10Comparable evidence
Infection (general)1/101/10Comparable evidence
Inflammation (general)1/101/10Comparable evidence
Skin irritation1/101/10Comparable evidence
Wounds1/101/10Comparable evidence

Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.

Key Constituents

Triterpenoid saponins (glycyrrhizin/glycyrrhizic acid)[1]

The principal sweet-tasting compound, about 50 times sweeter than sucrose; responsible for the anti-inflammatory, antiviral and gastroprotective activity and also for the pseudoaldosteronism risk on prolonged high-dose use.

SaponinsGlycyrrhizin
Flavonoids and isoflavones (liquiritin, glabridin)[1]

Antioxidant and antimicrobial polyphenols, including the skin-lightening compound glabridin.

Flavonoids
Coumarins and sterols[1]

Minor supporting constituents of the root.

Melanin-rich pigments and betulinic acid derivatives[1]

Chaga's dark colour comes from melanin-like pigments; it also concentrates betulinic-acid-type triterpenes absorbed from its birch host, associated with antioxidant and anticancer research interest.

Polysaccharides (beta-glucans)[4]

Immunomodulatory polysaccharides contributing to the traditional tonic and immune-support use.

Polysaccharides
Phenolic compounds[4]

Antioxidant phenolics contributing to chaga's free-radical-scavenging activity.

Phenolic compounds

Pharmacological Actions

Anti-inflammatory[1, 3, 4, 9, 11, 13, 14, 15]
Antimicrobial[8, 13, 14, 15]
Antispasmodic[13, 14, 15]

Antispasmodic (cramp easing)

Antiviral[13, 14, 15]
Expectorant[13, 14, 15]
Gastroprotective[13, 14, 15]
Immunomodulator / immune support[13, 14, 15]
Anti-inflammatory[4, 5, 9, 13, 15, 19, 27, 30, 38, 39, 40]
Anticancer (preclinical)[15, 17, 21, 22, 26, 28, 31, 38]
Antimicrobial[38, 39, 40]
Antioxidant[8, 10, 12, 29, 35, 38, 39, 40]
Immunomodulator / immune support[2, 4, 7, 14, 16, 19, 26, 32, 37, 38, 39, 40]
Nephroprotective (kidney support)[20]
Neuroprotective / cognition support[24, 35]
Antidiabetic (blood-sugar lowering)[25, 31, 34, 36]
Hepatoprotective (liver support)[28]
Lipid-lowering[33, 36]

Traditional & Indicated Uses

Acid reflux[13, 14, 15]Traditional · 1/10

inferred from gastroprotective action

Evidence: 1
Label: Acid reflux
Arthritis / joint pain[13, 14, 15]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Arthritis / joint pain
Bronchitis[13, 14, 15]Traditional · 1/10

inferred from expectorant action

Evidence: 1
Label: Bronchitis
Cold & flu[13, 14, 15]Traditional · 1/10

inferred from antiviral action

Evidence: 1
Label: Cold & flu
Cough[13, 14, 15]Traditional · 1/10

inferred from expectorant action

Evidence: 1
Label: Cough
Immune support[13, 14, 15]Traditional · 1/10
Evidence: 1
Label: Immune support
Indigestion[13, 14, 15]Traditional · 1/10

inferred from gastroprotective action

Evidence: 1
Label: Indigestion
Infection (general)[13, 14, 15]Traditional · 1/10

inferred from antimicrobial action

Evidence: 1
Label: Infection (general)
Inflammation (general)[13, 14, 15]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Inflammation (general)
Menstrual cramps[13, 14, 15]Traditional · 1/10

inferred from antispasmodic action

Evidence: 1
Label: Menstrual cramps
Muscle spasm[13, 14, 15]Traditional · 1/10

inferred from antispasmodic action

Evidence: 1
Label: Muscle spasm
Respiratory support[13, 14, 15]Traditional · 1/10

inferred from expectorant action

Evidence: 1
Label: Respiratory support
Skin irritation[13, 14, 15]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Skin irritation
Wounds[13, 14, 15]Traditional · 1/10

inferred from antimicrobial action

Evidence: 1
Label: Wounds
Arthritis / joint pain[38, 39, 40]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Arthritis / joint pain
Cancer (anticancer research)[15, 21, 38]Traditional · 2/10

inferred from anticancer action

Evidence: 2
Label: Cancer (anticancer research)
Cold & flu[38, 39, 40]Traditional · 1/10

inferred from immunomodulator action

Evidence: 1
Label: Cold & flu
Immune support[14, 38, 39, 40]Traditional · 2/10
Evidence: 2
Label: Immune support
Infection (general)[38, 39, 40]Traditional · 1/10

inferred from antimicrobial action

Evidence: 1
Label: Infection (general)
Inflammation (general)[38, 39, 40]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Inflammation (general)
Metabolic support[38, 39, 40]Traditional · 1/10
Evidence: 1
Label: Metabolic support
Skin irritation[38, 39, 40]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Skin irritation
Wounds[38, 39, 40]Traditional · 1/10

inferred from antimicrobial action

Evidence: 1
Label: Wounds
Cognitive function[24, 35]Traditional · 2/10

Chaga-derived 3,4-DHBA protected against Parkinson's-related neurotoxicity (preclinical).

Evidence: 2
Label: Cognitive function
Cardiovascular / heart health[33]Traditional · 2/10

Chaga polysaccharide lowered lipids in vivo and in vitro.

Evidence: 2
Label: Cardiovascular / heart health

Safety, Cautions & Contraindications

Safety note[13, 14, 15]Caution

Avoid prolonged use of whole licorice root in large doses. May cause pseudoaldosteronism (hypertension, oedema, hypokalaemia). Contraindicated in hypertension, renal failure, liver disease, hypokalaemia, and pregnancy. DGL form is safer for prolonged gastric use. Interactions with antihypertensives, diuretics, and corticosteroids.

Safety note[13, 14, 15, 16]Caution

Duke (2002) rates licorice as ++ and documents extensive activities. Glycyrrhizin (the key compound) has anti-inflammatory, antiulcer, antiviral, and adrenal-stimulant properties. Duke highlights an important safety concern: chronic use of licorice can cause pseudoaldosteronism — sodium retention, potassium loss, edema, and hypertension — due to glycyrrhizin's inhibition of cortisol metabolism. This effect is typically seen with >50 g licorice/day for more than 6 weeks. Deglycyrrhizinated licorice (DGL) avoids this side effect. Dose: 5–15 g dried root daily. Contraindicated in hypertension, kidney disease, low potassium, liver cirrhosis, and in combination with diuretics or corticosteroids (Duke, 2002).

Safety note[38, 39, 40]Caution

Autoimmune conditions: Chaga can stimulate parts of the immune system—people with autoimmune diseases should be cautious.Blood thinners: Chaga contains compounds that may affect clotting—avoid large doses if on anticoagulants.Blood sugar meds: May slightly lower glucose—monitor if taking diabetes medication.Pregnancy & breastfeeding: Limited safety data—best avoided unless guided by a professional.Quality matters: Wild-harvested Chaga can accumulate heavy metals from trees and soil—source from reputable suppliers.

Safety note[38, 39, 40, 41]Info

Duke (2002) does not include a dedicated entry for chaga (Inonotus obliquus) in the Handbook of Medicinal Herbs, Second Edition, as this medicinal fungus was not widely documented in Western herbal literature at that time (Duke, 2002).

External Ids

Gbif: 2965732
Wikidata: Q257106
Gbif: 2521089
Wikidata: Q1956937

Botanical Description

Herbaceous perennial legume with pinnately compound leaves of small, oval, slightly sticky leaflets. Pale blue-violet to lilac pea-like flowers are borne in loose spikes, followed by small, flattened, oblong pods. The sweet-tasting rhizome and root system, brownish-grey outside and bright yellow inside, is the medicinal part, spreading extensively underground via stolons.[1]

Height: 1-1.5 m
Habit: Herbaceous perennial legume, spreading by underground stolons
Leaves: Pinnately compound, small oval leaflets, slightly sticky
Flowers: Pale blue-violet to lilac, pea-like, in loose spikes
Stem: Erect, branching
Root: Extensive, sweet-tasting rhizome and root system, brownish-grey outside, bright yellow inside
Fruit: Small, flattened, oblong pod
Flowering Period: June-August

Parasitic wood-decay fungus (not a true plant) that grows almost entirely inside the trunk of living birch trees, visible externally only as a hard, black, cracked, charcoal-like mass (a sclerotium, sometimes called a 'conk') erupting through the bark. Unlike typical mushrooms, chaga has no true cap, gills or stem; its fertile spore-producing surface develops later, hidden beneath the bark after the tree dies.[1]

Height: External mass 10-40 cm
Habit: Parasitic wood-decay fungus, growing mostly inside the host tree
Leaves: Not applicable (fungus)
Flowers: Not applicable (fungus); reproduces by spores
Stem: No true cap-and-stem structure; visible only as a hard black external mass (sclerotium)
Root: Fungal mycelium spreading through the living wood of the host tree
Fruit: Fertile spore-producing layer develops hidden beneath the bark, typically after the host tree dies
Flowering Period: The visible black mass persists and grows for years; not a seasonal fruiting body

Habitat

Grows in dry, sunny, deep-soiled sites, riverbanks and open scrub; native to the Mediterranean region and Western to Central Asia, and cultivated widely for its root.[1]

Grows almost exclusively as a parasite on living birch trees in cold, northern temperate and boreal forests of Europe, Russia, North America and Asia.[1]

Harvesting

The root and rhizome are dug in autumn from plants at least three to four years old, when glycyrrhizin content is highest, then cleaned and dried; sold whole, cut, or as processed extract.[1]

Parts: Root
Season: Autumn, from mature (3-4+ year) plants

The hard black external mass (conk) is chopped or broken away from the living birch trunk, ideally without killing the tree, then dried and broken into pieces or ground for use; sustainable harvesting (leaving part of the conk to regrow) is recommended given the fungus's slow growth.

Parts: Mycelium, Whole Plant

Traditional Uses

Licorice root is one of the oldest and most widely used herbs in the world, with a documented history across Chinese, Ayurvedic, Greek and European traditional medicine as a soothing demulcent and expectorant for coughs and sore throat, a gastroprotective remedy for stomach discomfort and ulcers, and a harmonising, sweetening addition to herbal formulas.[1]

Chaga has a long traditional use in Russian, Siberian, Baltic and Scandinavian folk medicine as a tonic remedy for digestive complaints, immune support and general vitality, traditionally taken as a dark, tea-like decoction; this traditional tonic reputation is now studied for its antioxidant, immunomodulatory and anti-inflammatory properties.[1, 4]

Preparations

Decoction[1]

Dried root simmered in water as a traditional soothing, expectorant and gastroprotective tea.

Standardised extract[1]

Root extract standardised to glycyrrhizin content, taken as capsules or lozenges.

Decoction[1]

Chunks of the dried black conk simmered gently in water for an extended period, producing a dark, tea-like traditional tonic.

Standardised extract[4]

Extract standardised to polysaccharide or polyphenol content, taken as capsules or powder.

Dosage

Whole root/decoction[12]

The EU herbal monograph gives, for adults and elderly, 1.5-2 g of the comminuted root in 150 mL of boiling water as an infusion or decoction 2 to 4 times daily, taken one cup after meals; a soft extract (DER 1:0.4-0.5) at 32 mg 2-3 times daily, not exceeding 160 mg daily, is also listed. The monograph directs that it is NOT to be used for more than 4 weeks, and is not recommended under 18 years - the duration limit matters because prolonged licorice use causes pseudoaldosteronism (sodium and water retention, potassium loss, raised blood pressure). Deglycyrrhizinated licorice (DGL) is preferred where prolonged use is intended. Educational reference only, not a prescription.

Not documented

References

REF-0826, REF-0827, REF-0828, REF-2187, REF-2188, REF-2189, REF-2190, REF-2191, REF-2192, REF-2193, REF-2194
REF-0848, REF-0849, REF-0850, REF-2195, REF-2196, REF-2197, REF-2198, REF-2199, REF-2200, REF-2201, REF-2202, REF-2203, REF-2204, REF-2969, REF-2970, REF-2971, REF-2972, REF-2973, REF-2974, REF-2975, REF-2976, REF-2977, REF-2978, REF-2979, REF-2980, REF-2981, REF-2982, REF-2983, REF-2984, REF-2985, REF-2986, REF-2987, REF-2988, REF-2989, REF-2990, REF-2991, REF-2992

Drug Class Interactions

Safety note[17, 18, 19, 20]Caution
Drug Class: antihypertensives
Mechanism: Licorice (glycyrrhizic acid) can cause sodium retention, potassium loss and raised blood pressure (pseudoaldosteronism), which can oppose blood-pressure medicines. Meta-analyses of randomised trials confirm that glycyrrhizic acid raises systolic and diastolic blood pressure, and a crossover trial found this even at a low daily dose (100 mg). Avoid regular or high licorice intake if you take blood-pressure medicines.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
Safety note[17, 18]Caution
Drug Class: cardiac-glycosides
Mechanism: Licorice-induced potassium loss can increase the risk of digoxin toxicity; a meta-analysis confirms licorice lowers plasma potassium, and low potassium makes the heart more sensitive to cardiac glycosides. Avoid regular or high intake.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
Safety note[18]Caution
Drug Class: diuretics
Mechanism: Licorice (glycyrrhizic acid) causes the body to lose potassium; combined with potassium-wasting water tablets (thiazide or loop diuretics such as hydrochlorothiazide or furosemide) this can add up to dangerously low potassium, which a meta-analysis confirms licorice lowers. Licorice also works against potassium-sparing diuretics such as spironolactone by mimicking aldosterone. Avoid regular or high licorice intake with any diuretic.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03

Not documented

Lookalikes Review

Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07
Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07

References & Sources

  1. Pastorino, G., Cornara, L., Soares, S., Rodrigues, F. and Oliveira, M.B.P.P (2018) 'Liquorice (Glycyrrhiza glabra): A phytochemical and pharmacological review', Phytotherapy Research, 32(12), pp. 2323-2339. doi:10.1002/ptr.6178 Traditional / reference
    https://doi.org/10.1002/ptr.6178
  2. Nazari, S., Rameshrad, M. and Hosseinzadeh, H (2017) 'Toxicological Effects of Glycyrrhiza glabra (Licorice): A Review', Phytotherapy Research, 31(11), pp. 1635-1650. doi:10.1002/ptr.5893 Traditional / reference
    https://doi.org/10.1002/ptr.5893
  3. El-Saber Batiha, G., Magdy Beshbishy, A., El-Mleeh, A., Abdel-Daim, M.M. and Prasad Devkota, H (2020) 'Traditional Uses, Bioactive Chemical Constituents, and Pharmacological and Toxicological Activities of Glycyrrhiza glabra L. (Fabaceae)', Biomolecules, 10(3), pp. 352. doi:10.3390/biom10030352 Traditional / reference
    https://doi.org/10.3390/biom10030352
  4. Wahab, S., Annadurai, S., Abullais, S.S., Das, G., Ahmad, W., Ahmad, M.F., Kandasamy, G., Vasudevan, R., Ali, M.S. and Amir, M (2021) 'Glycyrrhiza glabra (licorice): a comprehensive review on its phytochemistry, biological activities, clinical evidence and toxicology', Plants, 10(12), pp. 2751. doi:10.3390/plants10122751 Meta-analysis / review
    https://doi.org/10.3390/plants10122751
  5. Markina, Y.V., Kirichenko, T.V., Markin, A.M., Yudina, I.Y., Starodubova, A.V., Sobenin, I.A. and Orekhov, A.N (2022) 'Atheroprotective effects of Glycyrrhiza glabra L', Molecules, 27(15), pp. 4697. doi:10.3390/molecules27154697 Meta-analysis / review
    https://doi.org/10.3390/molecules27154697
  6. Jafari, F., Jafari, M., Moghadam, A.T., Emami, S.A., Jamialahmadi, T., Mohammadpour, A.H. and Sahebkar, A (2021) 'A review of Glycyrrhiza glabra (licorice) effects on metabolic syndrome', Advances in Experimental Medicine and Biology, 1328, pp. 385-400. doi:10.1007/978-3-030-73234-9_25 Meta-analysis / review
    https://doi.org/10.1007/978-3-030-73234-9_25
  7. Schmid, C., Dawid, C., Peters, V. and Hofmann, T (2018) 'Saponins from European licorice roots (Glycyrrhiza glabra)', Journal of Natural Products, 81(8), pp. 1734-1744. doi:10.1021/acs.jnatprod.8b00022 Preclinical
    https://doi.org/10.1021/acs.jnatprod.8b00022
  8. Kalani, K., Chaturvedi, V., Alam, S., Khan, F. and Srivastava, S.K (2015) 'Anti-tubercular agents from Glycyrrhiza glabra', Current Topics in Medicinal Chemistry, 15(11), pp. 1043-1049. doi:10.2174/1568026615666150317223323 Preclinical
    https://doi.org/10.2174/1568026615666150317223323
  9. Frattaruolo, L., Carullo, G., Brindisi, M., Mazzotta, S., Bellissimo, L., Rago, V., Curcio, R., Dolce, V., Aiello, F. and Cappello, A.R (2019) 'Antioxidant and anti-inflammatory activities of flavanones from Glycyrrhiza glabra L. (licorice) leaf phytocomplexes: identification of licoflavanone as a modulator of NF-kB/MAPK pathway', Antioxidants, 8(6), pp. 186. doi:10.3390/antiox8060186 Preclinical
    https://doi.org/10.3390/antiox8060186
  10. Eltahir, A.O.E., Omoruyi, S.I., Augustine, T.N., Luckay, R.C. and Hussein, A.A (2024) 'Neuroprotective effects of Glycyrrhiza glabra total extract and isolated compounds', Pharmaceuticals, 17(7), pp. 852. doi:10.3390/ph17070852 Preclinical
    https://doi.org/10.3390/ph17070852
  11. Dastagir, G. and Rizvi, M.A (2016) 'Review - Glycyrrhiza glabra L. (liquorice)', Pakistan Journal of Pharmaceutical Sciences, 29(5), pp. 1727-1733. Meta-analysis / review
    https://scholar.google.com/scholar?q=Review%20-%20Glycyrrhiza%20glabra%20L.%20%28liquorice%29
  12. European Medicines Agency (HMPC) (2013) 'Community herbal monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf Traditional / reference
    https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
  13. Asl, M.N. and Hosseinzadeh, H (2008) 'Review of pharmacological effects of Glycyrrhiza sp', 22(6), pp. 709--724. Traditional / reference
    https://scholar.google.com/scholar?q=Review%20of%20pharmacological%20effects%20of%20Glycyrrhiza%20sp.
  14. Fiore, C. et al (2008) 'A history of the therapeutic use of liquorice in Europe', 99(3), pp. 317--324. doi:10.1016/j.jep.2005.04.015 Traditional / reference
    https://doi.org/10.1016/j.jep.2005.04.015
  15. WHO (1999) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
    https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants
  16. Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
    https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
  17. Takahashi, K., Yoshino, T., Maki, Y., Ishiuchi, K., Namiki, T., Ogawa-Ochiai, K., Minamizawa, K., Makino, T., Nakamura, T., Mimura, M. and Watanabe, K (2019) 'Identification of glycyrrhizin metabolites in humans and of a potential biomarker of liquorice-induced pseudoaldosteronism', Archives of Toxicology, 93(11), pp. 3111-3119. doi:10.1007/s00204-019-02588-2 Clinical study
    https://doi.org/10.1007/s00204-019-02588-2
  18. Penninkilampi, R., Eslick, E.M. and Eslick, G.D (2017) 'The association between consistent licorice ingestion, hypertension and hypokalaemia: a systematic review and meta-analysis', Journal of Human Hypertension, 31(11), pp. 699-707. doi:10.1038/jhh.2017.45 Meta-analysis / review
    https://doi.org/10.1038/jhh.2017.45
  19. Wu, T., Yang, J., Xia, J. and Sun, G (2024) 'Effects of licorice functional components intakes on blood pressure: a systematic review with meta-analysis and network toxicology', Nutrients, 16(21), pp. 3768. doi:10.3390/nu16213768 Meta-analysis / review
    https://doi.org/10.3390/nu16213768
  20. af Geijerstam, P., Joelsson, A., Radholm, K. and Nystrom, F.H (2024) 'A low dose of daily licorice intake affects renin, aldosterone, and home blood pressure in a randomized crossover trial', The American Journal of Clinical Nutrition, 119(3), pp. 682-691. doi:10.1016/j.ajcnut.2024.01.011 Randomized trial
    https://doi.org/10.1016/j.ajcnut.2024.01.011
  1. Camilleri, E., Blundell, R., Baral, B., Karpinski, T.M. et al (2024) 'A brief overview of the medicinal and nutraceutical importance of Inonotus obliquus (chaga) mushrooms', Heliyon, 10(15), pp. e35638. doi:10.1016/j.heliyon.2024.e35638 Traditional / reference
    https://doi.org/10.1016/j.heliyon.2024.e35638
  2. Lu, Y., Jia, Y., Xue, Z., Li, N. et al (2021) 'Recent Developments in Inonotus obliquus (Chaga mushroom) Polysaccharides: Isolation, Structural Characteristics, Biological Activities and Application', Polymers (Basel), 13(9), pp. 1441. doi:10.3390/polym13091441 Traditional / reference
    https://doi.org/10.3390/polym13091441
  3. Kobus, Z., Krzywicka, M., Blicharz-Kania, A., Bosacka, A. et al (2024) 'Impact of Incorporating Dried Chaga Mushroom (Inonotus obliquus) into Gluten-Free Bread on Its Antioxidant and Sensory Characteristics', Molecules, 29(16), pp. 3801. doi:10.3390/molecules29163801 Preclinical
    https://doi.org/10.3390/molecules29163801
  4. Szychowski, K.A., Skora, B., Pomianek, T. and Gminski, J (2020) 'Inonotus obliquus - from folk medicine to clinical use', Journal of Traditional and Complementary Medicine, 11(4), pp. 293-302. doi:10.1016/j.jtcme.2020.08.003 Meta-analysis / review
    https://doi.org/10.1016/j.jtcme.2020.08.003
  5. Javed, S., Mitchell, K., Sidsworth, D., Sellers, S.L., Reutens-Hernandez, J., Massicotte, H.B., Egger, K.N., Lee, C.H. and Payne, G.W (2019) 'Inonotus obliquus attenuates histamine-induced microvascular inflammation', PLoS One, 14(8), pp. e0220776. doi:10.1371/journal.pone.0220776 Preclinical
    https://doi.org/10.1371/journal.pone.0220776
  6. Zou, C., Hou, Z., Bai, M., Guo, R., Lin, B., Wang, X., Huang, X. and Song, S (2020) 'Highly modified steroids from Inonotus obliquus', Organic & Biomolecular Chemistry, 18(20), pp. 3908-3916. doi:10.1039/d0ob00474j Preclinical
    https://doi.org/10.1039/d0ob00474j
  7. Zhong, X.H., Ren, K., Lu, S.J., Yang, S.Y. and Sun, D.Z (2009) 'Progress of research on Inonotus obliquus', Chinese Journal of Integrative Medicine, 15(2), pp. 156-160. doi:10.1007/s11655-009-0156-2 Meta-analysis / review
    https://doi.org/10.1007/s11655-009-0156-2
  8. Burmasova, M.A., Utebaeva, A.A., Sysoeva, E.V. and Sysoeva, M.A (2019) 'Melanins of Inonotus obliquus: bifidogenic and antioxidant properties', Biomolecules, 9(6), pp. 248. doi:10.3390/biom9060248 Preclinical
    https://doi.org/10.3390/biom9060248
  9. Sun, Y., Deng, X., Li, Z., Dong, Y., Jiang, W., Ma, Y., Zhou, W., Zhu, T., Wang, G., Liu, S. and Hu, B (2022) 'Polysaccharide derived from Inonotus obliquus inhibits lipopolysaccharide-induced acute endometritis in mice', American Journal of Translational Research, 14(11), pp. 8332-8342. Preclinical
    https://scholar.google.com/scholar?q=Polysaccharide%20derived%20from%20Inonotus%20obliquus%20inhibits%20lipopolysaccharide-induced%20acute%20endometritis%20in%20mice
  10. Ishfaq, P.M., Mishra, S., Mishra, A., Ahmad, Z., Gayen, S., Jain, S.K., Tripathi, S. and Mishra, S.K (2022) 'Inonotus obliquus aqueous extract prevents histopathological alterations in liver induced by environmental toxicant Microcystin', Current Research in Pharmacology and Drug Discovery, 3, pp. 100118. doi:10.1016/j.crphar.2022.100118 Preclinical
    https://doi.org/10.1016/j.crphar.2022.100118
  11. Peng, A., Liu, S., Fang, L., Zhu, Z., Zhou, Y., Yue, S., Ma, Z., Liu, X., Xue, S., Qiu, Y. and Qi, R (2022) 'Inonotus obliquus and its bioactive compounds alleviate non-alcoholic fatty liver disease via regulating FXR/SHP/SREBP-1c axis', European Journal of Pharmacology, 921, pp. 174841. doi:10.1016/j.ejphar.2022.174841 Preclinical
    https://doi.org/10.1016/j.ejphar.2022.174841
  12. Zhang, Y., Liu, Q., Sun, Y. and Jiang, J (2023) 'Inonotus obliquus sclerotia epidermis were different from internal tissues in compound composition, antioxidant activity, and associated fungi', FEMS Microbiology Letters, 370, pp. fnad126. doi:10.1093/femsle/fnad126 Preclinical
    https://doi.org/10.1093/femsle/fnad126
  13. Yu, S., Lai, Z., Xue, H., Zhu, J., Yue, G., Wang, J. and Jin, L.H (2024) 'Inonotus obliquus aqueous extract inhibits intestinal inflammation and insulin metabolism defects in Drosophila', Toxicology Mechanisms and Methods, 34(9), pp. 970-984. doi:10.1080/15376516.2024.2368795 Preclinical
    https://doi.org/10.1080/15376516.2024.2368795
  14. Wold, C.W. and Christopoulos, P. and Arias, M. and Dzovor, D.E. and Øynebråten, I. and Corthay, A. and Inngjerdingen, K.T (2024) 'Fungal polysaccharides from Inonotus obliquus are agonists for Toll-like receptors and induce macrophage anti-cancer activity', Communications Biology. doi:10.1038/s42003-024-05853-y Preclinical
    https://doi.org/10.1038/s42003-024-05853-y
  15. Li, J. and Qu, C. and Li, F. and Chen, Y. and Zheng, J. and Xiao, Y. and Jin, Q. and Jin, G. and Huang, X. and Jin, D (2021) 'Inonotus obliquus Polysaccharide Ameliorates Azoxymethane/Dextran Sulfate Sodium-Induced Colitis-Associated Cancer in Mice via Activation of the NLRP3 Inflammasome', Frontiers in Pharmacology. doi:10.3389/fphar.2020.621835 Preclinical
    https://doi.org/10.3389/fphar.2020.621835
  16. Wold, C.W. and Gerwick, W.H. and Wangensteen, H. and Inngjerdingen, K.T (2020) 'Bioactive triterpenoids and water-soluble melanin from Inonotus obliquus (Chaga) with immunomodulatory activity', Journal of Functional Foods. doi:10.1016/j.jff.2020.104025 Preclinical
    https://doi.org/10.1016/j.jff.2020.104025
  17. Kim, J. and Yang, S. and Hwang, A.Y. and Cho, H. and Hwang, K.T (2020) 'Composition of Triterpenoids in Inonotus obliquus and Their Anti-Proliferative Activity on Cancer Cell Lines', Molecules. doi:10.3390/molecules25184066 Preclinical
    https://doi.org/10.3390/molecules25184066
  18. Duru, K.C. and Kovaleva, E.G. and Данилова, И.Г. and Bijl, P.V.D (2019) 'The pharmacological potential and possible molecular mechanisms of action of Inonotus obliquus from preclinical studies', Phytotherapy Research. doi:10.1002/ptr.6384 Preclinical
    https://doi.org/10.1002/ptr.6384
  19. Hu, Y. and Teng, C. and Yu, S. and Wang, X. and Liang, J. and Bai, X. and Dong, L. and Song, T. and Yu, M. and Qu, J (2017) 'Inonotus obliquus polysaccharide regulates gut microbiota of chronic pancreatitis in mice', AMB Express. doi:10.1186/s13568-017-0341-1 Preclinical
    https://doi.org/10.1186/s13568-017-0341-1
  20. Chou, Y. and Kan, W. and Chang, C. and Peng, Y. and Wang, H. and Yu, W. and Cheng, Y. and Jhang, Y. and Liu, H. and Chuu, J (2016) 'Renal Protective Effects of Low Molecular Weight of Inonotus obliquus Polysaccharide (LIOP) on HFD/STZ-Induced Nephropathy in Mice', International Journal of Molecular Sciences. doi:10.3390/ijms17091535 Preclinical
    https://doi.org/10.3390/ijms17091535
  21. Arata, S. and Watanabe, J. and Maeda, M. and Yamamoto, M. and Matsuhashi, H. and Mochizuki, M. and Kagami, N. and Honda, K. and Inagaki, M (2016) 'Continuous intake of the Chaga mushroom (Inonotus obliquus) aqueous extract suppresses cancer progression and maintains body temperature in mice', Heliyon. doi:10.1016/j.heliyon.2016.e00111 Preclinical
    https://doi.org/10.1016/j.heliyon.2016.e00111
  22. Lee, K.R. and Lee, J.S. and Kim, Y.R. and Song, I.G. and Hong, E.K (2014) 'Polysaccharide from Inonotus obliquus inhibits migration and invasion in B16-F10 cells by suppressing MMP-2 and MMP-9 via downregulation of NF-κB signaling pathway', Oncology Reports. doi:10.3892/or.2014.3103 Preclinical
    https://doi.org/10.3892/or.2014.3103
  23. Song, F. and Liu, Y. and Kong, X. and Chang, W. and Song, G (2013) 'Progress on Understanding the Anticancer Mechanisms of Medicinal Mushroom: Inonotus Obliquus', Asian Pacific Journal of Cancer Prevention. doi:10.7314/apjcp.2013.14.3.1571 Preclinical
    https://doi.org/10.7314/apjcp.2013.14.3.1571
  24. Gunjima, K. and Tomiyama, R. and Takakura, K. and Yamada, T. and Hashida, K. and Nakamura, Y. and Konishi, T. and Matsugo, S. and Hori, O (2013) '3,4‐Dihydroxybenzalacetone Protects Against Parkinson's Disease‐Related Neurotoxin 6‐OHDA Through Akt/Nrf2/Glutathione Pathway', Journal of Cellular Biochemistry. doi:10.1002/jcb.24643 Preclinical
    https://doi.org/10.1002/jcb.24643
  25. Geng, Y. and Lu, Z. and Huang, W. and Xu, H. and Shi, J. and Xu, Z (2013) 'Bioassay-Guided Isolation of DPP-4 Inhibitory Fractions from Extracts of Submerged Cultured of Inonotus obliquus', Molecules. doi:10.3390/molecules18011150 Preclinical
    https://doi.org/10.3390/molecules18011150
  26. Zhang, L. and Fan, C. and Liu, S. and Zang, Z. and Jiao, L. and Zhang, L (2011) 'Chemical composition and antitumor activity of polysaccharide from Inonotus obliquus', Journal of Medicinal Plants Research. doi:10.5897/jmpr.9000346 Preclinical
    https://doi.org/10.5897/jmpr.9000346
  27. Choi, S. and Hur, S.J. and An, C.S. and Jeon, Y.H. and Jeoung, Y.J. and Bak, J.P. and Lim, B.O (2010) 'Anti-Inflammatory Effects ofInonotus obliquusin Colitis Induced by Dextran Sodium Sulfate', Journal of Biomedicine and Biotechnology. doi:10.1155/2010/943516 Preclinical
    https://doi.org/10.1155/2010/943516
  28. Youn, M. and Kim, J. and Park, S. and Kim, Y. and Kim, S. and Lee, J.S. and Chai, K.Y. and Kim, H. and Cui, M. and So, H.S. and Kim, K. and Park, R (2008) 'Chaga mushroom (Inonotus obliquus ) induces G0/G1 arrest and apoptosis in human hepatoma HepG2 cells', World Journal of Gastroenterology. doi:10.3748/wjg.14.511 Preclinical
    https://doi.org/10.3748/wjg.14.511
  29. Nakajima, Y. and Sato, Y. and Konishi, T (2007) 'Antioxidant Small Phenolic Ingredients in Inonotus obliquus (persoon) Pilat (Chaga)', Chemical and Pharmaceutical Bulletin. doi:10.1248/cpb.55.1222 Preclinical
    https://doi.org/10.1248/cpb.55.1222
  30. Kim, H. and Yoon, D. and Kim, C. and Shrestha, B. and Chang, W. and Lim, S. and Lee, W. and Han, S. and Lee, J. and Lim, M. and Kim, G. and Choi, S. and Song, W.O. and Sung, J. and Hwang, K (2007) 'Ethanol Extract of Inonotus obliquus Inhibits Lipopolysaccharide-Induced Inflammation in RAW 264.7 Macrophage Cells', Journal of Medicinal Food. doi:10.1089/jmf.2006.156 Preclinical
    https://doi.org/10.1089/jmf.2006.156
  31. Mizuno, T. and Zhuang, C. and Abe, K. and Okamoto, H. and Kiho, T. and Ukai, S. and Leclerc, S. and Meijer, L (1999) 'Antitumor and Hypoglycemic Activities of Polysaccharides from the Sclerotia and Mycelia of Inonotus obliquus (Pers.: Fr.) Pil. (Aphyllophoromycetideae)', International journal of medicinal mushrooms. doi:10.1615/intjmedmushr.v1.i4.20 Preclinical
    https://doi.org/10.1615/intjmedmushr.v1.i4.20
  32. Su, L. and Xin, C. and Yang, J. and Dong, L. and Mei, H. and Dai, X. and Wang, Q (2022) 'A polysaccharide from Inonotus obliquus ameliorates intestinal barrier dysfunction in mice with type 2 diabetes mellitus', International Journal of Biological Macromolecules. doi:10.1016/j.ijbiomac.2022.06.071 Preclinical
    https://doi.org/10.1016/j.ijbiomac.2022.06.071
  33. Yang, M. and Hu, D. and Cui, Z. and Li, H. and Man, C. and Jiang, Y (2021) 'Lipid-Lowering Effects of Inonotus obliquus Polysaccharide In Vivo and In Vitro', Foods. doi:10.3390/foods10123085 Preclinical
    https://doi.org/10.3390/foods10123085
  34. Wang, J. and Hu, W. and Li, L. and Huang, X. and Liu, Y. and Wang, D. and Teng, L (2017) 'Antidiabetic activities of polysaccharides separated from Inonotus obliquus via the modulation of oxidative stress in mice with streptozotocin-induced diabetes', PLoS ONE. doi:10.1371/journal.pone.0180476 Preclinical
    https://doi.org/10.1371/journal.pone.0180476
  35. Giridharan, V.V. and Thandavarayan, R.A. and Konishi, T (2011) 'Amelioration of scopolamine induced cognitive dysfunction and oxidative stress by Inonotus obliquus– a medicinal mushroom', Food & Function. doi:10.1039/c1fo10037h Preclinical
    https://doi.org/10.1039/c1fo10037h
  36. Lee, J. and Hyun, C (2014) 'Insulin‐Sensitizing and Beneficial Lipid‐Metabolic Effects of the Water‐Soluble Melanin Complex Extracted from Inonotus obliquus', Phytotherapy Research. doi:10.1002/ptr.5131 Preclinical
    https://doi.org/10.1002/ptr.5131
  37. Kim, Y (2005) 'Immunomodulatory Activity of the Water Extract from Medicinal MushroomInonotus obliquus', Mycobiology. doi:10.4489/myco.2005.33.3.158 Preclinical
    https://doi.org/10.4489/myco.2005.33.3.158
  38. Géry, A., Dubreule, C., André, V., Rioult, J.P., Bouchart, V., Heutte, N., Eldin de Pécoulas, P., Krivomaz, T. and Garon, D (2018) 'Chaga (Inonotus obliquus), a future potential medicinal fungus in oncology? A chemical study and a comparison of the cytotoxicity against human lung adenocarcinoma cells (A549) and human bronchial epithelial cells (BEAS-2B)', 17(3), pp. 832--843. doi:10.1177/1534735418757912 Traditional / reference
    https://doi.org/10.1177/1534735418757912
  39. Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
    https://powo.science.kew.org
  40. Shashkina, M.Ya., Shashkin, P.N. and Sergeev, A.V (2006) 'Chemical and medicobiological properties of chaga', 40(10), pp. 560--568. Traditional / reference
    https://scholar.google.com/scholar?q=Chemical%20and%20medicobiological%20properties%20of%20chaga
  41. Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
    https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition

Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.